239 related articles for article (PubMed ID: 22161775)
21. Epidermal growth factor receptor gene amplification in surgical resected Japanese lung cancer.
Sasaki H; Shimizu S; Okuda K; Kawano O; Yukiue H; Yano M; Fujii Y
Lung Cancer; 2009 Jun; 64(3):295-300. PubMed ID: 19058870
[TBL] [Abstract][Full Text] [Related]
22. Protein expression and gene amplification of epidermal growth factor receptor in thymomas.
Ionescu DN; Sasatomi E; Cieply K; Nola M; Dacic S
Cancer; 2005 Feb; 103(3):630-6. PubMed ID: 15630697
[TBL] [Abstract][Full Text] [Related]
23. Detection of DNA copy number changes and oncogenic signaling abnormalities from gene expression data reveals MYC activation in high-grade papillary renal cell carcinoma.
Furge KA; Chen J; Koeman J; Swiatek P; Dykema K; Lucin K; Kahnoski R; Yang XJ; Teh BT
Cancer Res; 2007 Apr; 67(7):3171-6. PubMed ID: 17409424
[TBL] [Abstract][Full Text] [Related]
24. Molecular alterations in AKT and its protein activation in human lung carcinomas.
Dobashi Y; Kimura M; Matsubara H; Endo S; Inazawa J; Ooi A
Hum Pathol; 2012 Dec; 43(12):2229-40. PubMed ID: 22748472
[TBL] [Abstract][Full Text] [Related]
25. Epidermal growth factor receptor copy number alterations correlate with poor clinical outcome in patients with head and neck squamous cancer.
Temam S; Kawaguchi H; El-Naggar AK; Jelinek J; Tang H; Liu DD; Lang W; Issa JP; Lee JJ; Mao L
J Clin Oncol; 2007 Jun; 25(16):2164-70. PubMed ID: 17538160
[TBL] [Abstract][Full Text] [Related]
26. Chromosome 7 aneusomy in metaplastic breast carcinomas with chondroid, squamous, and spindle-cell differentiation.
Gwin K; Lezon-Geyda K; Harris L; Tavassoli FA
Int J Surg Pathol; 2011 Feb; 19(1):20-5. PubMed ID: 19411277
[TBL] [Abstract][Full Text] [Related]
27. EGFR in gastric carcinomas: prognostic significance of protein overexpression and high gene copy number.
Kim MA; Lee HS; Lee HE; Jeon YK; Yang HK; Kim WH
Histopathology; 2008 May; 52(6):738-46. PubMed ID: 18397279
[TBL] [Abstract][Full Text] [Related]
28. Frequent intratumoral heterogeneity of EGFR gene copy gain in non-small cell lung cancer.
Grob TJ; Hoenig T; Clauditz TS; Atanackovic D; Koenig AM; Vashist YK; Klose H; Simon R; Pantel K; Izbicki JR; Bokemeyer C; Sauter G; Wilczak W
Lung Cancer; 2013 Mar; 79(3):221-7. PubMed ID: 23238037
[TBL] [Abstract][Full Text] [Related]
29. Identification of gains on 1q and epidermal growth factor receptor overexpression as independent prognostic markers in intracranial ependymoma.
Mendrzyk F; Korshunov A; Benner A; Toedt G; Pfister S; Radlwimmer B; Lichter P
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2070-9. PubMed ID: 16609018
[TBL] [Abstract][Full Text] [Related]
30. Cyclin D1 expression in renal carcinomas and oncocytomas: an immunohistochemical study.
Lin BT; Brynes RK; Gelb AB; McCourty A; Amin MB; Medeiros LJ
Mod Pathol; 1998 Nov; 11(11):1075-81. PubMed ID: 9831205
[TBL] [Abstract][Full Text] [Related]
31. Proliferating cell nuclear antigen and epidermal growth factor receptor (EGFr) status in renal cell carcinoma patients with polysomy of chromosome 7.
Amare Kadam PS; Varghese C; Bharde SH; Narasimhamoorthy NK; Desai S; Advani SH; Havaldar R; Kulkarni JN
Cancer Genet Cytogenet; 2001 Mar; 125(2):139-46. PubMed ID: 11369057
[TBL] [Abstract][Full Text] [Related]
32. Modulation of pro-epidermal growth factor, pro-transforming growth factor alpha and epidermal growth factor receptor gene expression in human renal carcinomas.
Petrides PE; Bock S; Bovens J; Hofmann R; Jakse G
Cancer Res; 1990 Jul; 50(13):3934-9. PubMed ID: 2354442
[TBL] [Abstract][Full Text] [Related]
33. EGFR genomic gain and aberrant pathway signaling in pancreatic cancer patients.
Tzeng CW; Frolov A; Frolova N; Jhala NC; Howard JH; Vickers SM; Buchsbaum DJ; Heslin MJ; Arnoletti JP
J Surg Res; 2007 Nov; 143(1):20-6. PubMed ID: 17950068
[TBL] [Abstract][Full Text] [Related]
34. Epidermal growth factor receptor protein expression and gene amplification in small cell carcinoma of the urinary bladder.
Wang X; Zhang S; MacLennan GT; Eble JN; Lopez-Beltran A; Yang XJ; Pan CX; Zhou H; Montironi R; Cheng L
Clin Cancer Res; 2007 Feb; 13(3):953-7. PubMed ID: 17289890
[TBL] [Abstract][Full Text] [Related]
35. The prognostic significance of epidermal growth factor receptor expression in clear-cell renal cell carcinoma: a call for standardized methods for immunohistochemical evaluation.
Cohen D; Lane B; Jin T; Magi-Galluzzi C; Finke J; Rini BI; Bukowski RM; Zhou M
Clin Genitourin Cancer; 2007 Mar; 5(4):264-70. PubMed ID: 17553206
[TBL] [Abstract][Full Text] [Related]
36. Differential expression of caveolin-1 in renal neoplasms.
Tamaskar I; Choueiri TK; Sercia L; Rini B; Bukowski R; Zhou M
Cancer; 2007 Aug; 110(4):776-82. PubMed ID: 17594718
[TBL] [Abstract][Full Text] [Related]
37. Minichromosome maintenance protein 2 expression in normal kidney and renal cell carcinomas: relationship to tumor dormancy and potential clinical utility.
Rodins K; Cheale M; Coleman N; Fox SB
Clin Cancer Res; 2002 Apr; 8(4):1075-81. PubMed ID: 11948116
[TBL] [Abstract][Full Text] [Related]
38. EGFR alterations in pancreatic ductal adenocarcinoma: a chromogenic in situ hybridization analysis based on tissue microarrays.
Tsiambas E; Karameris A; Lazaris AC; Talieri M; Triantafillidis JK; Cheracakis P; Manaios L; Gerontopoulos K; Patsouris E; Lygidakis NJ
Hepatogastroenterology; 2006; 53(69):452-7. PubMed ID: 16795991
[TBL] [Abstract][Full Text] [Related]
39. Epidermal growth factor receptor--its expression and copy numbers of EGFR gene in patients with head and neck squamous cell carcinomas.
Mrhalova M; Plzak J; Betka J; Kodet R
Neoplasma; 2005; 52(4):338-43. PubMed ID: 16059652
[TBL] [Abstract][Full Text] [Related]
40. Significance of Fas expression alteration during tumor progression of renal cell carcinoma.
Sejima T; Miyagawa I
Int J Urol; 2006 Mar; 13(3):257-64. PubMed ID: 16643620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
